|
|
JW»ý¸í°úÇÐ, EU-GMPÀÎÁõ ȹµæ |
±è»ç¶û ±âÀÚ |
2018-04-04 08:46 |
´ë¿øÁ¦¾à, NDRÈıâ: â»çÀÌ·¡ óÀ½À¸·Î ¿ÃÇØ 3,000¾ï¿ø´ë ¸ÅÃâ ´Þ¼º Àü¸Á.. |
¹Úº´¿ì ±âÀÚ |
2018-04-03 05:16 |
Á¦¾à/¹ÙÀÌ¿À Á¤¸®³ëÆ® Weekly :Á¤ºÎ Áö¿ø Áõ°¡¿Í °ü·Ã ÅõÀÚ ±ÞÁõ |
¹Úº´¿ì ±âÀÚ |
2018-04-02 15:19 |
Healthcare Weekly Chart Boo(3¿ù 4ÁÖÂ÷ (3¿ù 26ÀÏ-3¿ù 30ÀÏ)-»ï¼ºÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:55 |
Meritz Á¦¾à/¹ÙÀÌ¿À Weekly:1Q18 ±Û·Î¹ú Deal Æ®·»µå Review |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:42 |
¶óÀÎ |
ÇコÄɾî Daily(4/2)-½ÅÇѱÝÀ¶ÅõÀÚ |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:32 |
Coherus Biosciences(CHRS), Neulasta Biosimilar First Mover |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:28 |
Amgen Inc.(AMGN),Humira Biosimilar First Mover |
±è»ç¶û ±âÀÚ |
2018-04-02 14:22 |
¼¿Æ®¸®¿ÂÇコÄɾî, º»°ÝÀû ¼ºÀå±Ëµµ ÁøÀÔ |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:17 |
¼¿Æ®¸®¿Â, The Biosimilar King |
¹Úº´¿ì ±âÀÚ |
2018-04-02 14:09 |
¶óÀÎ |
Çѱ¹ÀÇ ¹ÙÀÌ¿À»ê¾÷ ÇÑ´Ü°è´õ µµ¾à-À̺£½ºÆ®ÅõÀÚÁõ±Ç |
±è»ç¶û ±âÀÚ |
2018-04-02 13:27 |
Á¦¾à¹ÙÀÌ¿À, 4¿ù Monthly: ³ôÀº Multiple À¯Áö °¡´É |
¹Úº´¿ì ±âÀÚ |
2018-04-02 11:57 |
¾¾Á¨, ½ÅÁ¦Ç° ´ë°Å Ãâ½Ã·Î °í¼ºÀå º»°ÝÈ |
±è»ç¶û ±âÀÚ |
2018-04-02 09:15 |
¸ÞµðÅ彺, 1ºÐ±â QoQ·Îµµ Áõ°¡ 4ºÐ±â ¶Ù¾î³Ñ´Â »ç»ó ÃÖ´ë ½ÇÀû |
±è»ç¶û ±âÀÚ |
2018-04-02 09:09 |
Á¾±Ù´ç, ºÎÁøÇß´ø ÁÖ°¡ µ¹Æı¸´Â R&D |
¹Úº´¿ì ±âÀÚ |
2018-04-02 08:54 |
¶óÀÎ |
À¯ÇѾçÇ൵ R&D±â´ë°¨ ÀÖ½À´Ï´Ù |
±è»ç¶û ±âÀÚ |
2018-04-02 08:48 |
³ì½ÊÀÚ, IVIG ÃÖÁ¾½ÃÆÇ Çã°¡ °ü·Ã ÁßÀå±âÀû º¸À¯ |
±è»ç¶û ±âÀÚ |
2018-04-02 08:41 |
Çѹ̾àÇ°, AACR, ASCO, ADA ¿¬ÀÌÀº ÇÐȸ¹ßÇ¥·Î R&D µ¿·ÂÈ®º¸ |
¹Úº´¿ì ±âÀÚ |
2018-04-02 08:35 |
[ÁýÁߺм®]Á¦¾à¹ÙÀÌ¿À ¼½ÅÍ´Â Á¾¸ñÀåÀ¸·Î ¼ºÀåÁß |
¹Úº´¿ì ±âÀÚ |
2018-04-02 08:26 |
À¯ÇѾçÇà, 1ºÐ±â°¡ ÀúÁ¡-IBKÅõÀÚÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2018-03-30 09:36 |
|